|
US2642514A
(en)
|
1946-08-10 |
1953-06-16 |
American Cyanamid Co |
Ion exchange process with magnetic ion exchange resins
|
|
GB1239978A
(en)
|
1968-07-15 |
1971-07-21 |
Permutt Company Ltd |
Ion-exchange processes
|
|
US5516931A
(en)
|
1982-02-01 |
1996-05-14 |
Northeastern University |
Release tag compounds producing ketone signal groups
|
|
US4650750A
(en)
|
1982-02-01 |
1987-03-17 |
Giese Roger W |
Method of chemical analysis employing molecular release tag compounds
|
|
US5650270A
(en)
|
1982-02-01 |
1997-07-22 |
Northeastern University |
Molecular analytical release tags and their use in chemical analysis
|
|
US4709016A
(en)
|
1982-02-01 |
1987-11-24 |
Northeastern University |
Molecular analytical release tags and their use in chemical analysis
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US20020164788A1
(en)
|
1994-12-02 |
2002-11-07 |
The Wellcome Foundation Limited |
Humanized antibodies to CD38
|
|
ATE219517T1
(de)
|
1995-08-18 |
2002-07-15 |
Morphosys Ag |
Protein-/(poly)peptidbibliotheken
|
|
WO1998019705A1
(en)
|
1996-11-05 |
1998-05-14 |
Bristol-Myers Squibb Company |
Branched peptide linkers
|
|
US6326144B1
(en)
|
1998-09-18 |
2001-12-04 |
Massachusetts Institute Of Technology |
Biological applications of quantum dots
|
|
EP1115888B1
(en)
|
1998-09-24 |
2008-03-12 |
Indiana University Research and Technology Corporation |
Water-soluble luminescent quantum dots and bioconjugates thereof
|
|
US6927203B1
(en)
|
1999-08-17 |
2005-08-09 |
Purdue Research Foundation |
Treatment of metastatic disease
|
|
DK1487972T3
(en)
|
2002-02-21 |
2015-10-19 |
Inst Virology |
MN / CA IX-specific monoclonal antibodies generated from MN / CA IX-poor mice, as well as methods of use.
|
|
EP1569956B1
(en)
|
2002-12-12 |
2014-02-26 |
Tel Aviv University Future Technology Development L.P. |
Glycogen synthase kinase-3 inhibitors
|
|
EP1452868A2
(en)
|
2003-02-27 |
2004-09-01 |
Pepscan Systems B.V. |
Method for selecting a candidate drug compound
|
|
ES2541436T3
(es)
|
2004-02-06 |
2015-07-20 |
Morphosys Ag |
Anticuerpos humanos anti-CD38 y usos para ellos
|
|
CA2505655C
(en)
|
2004-04-28 |
2013-07-09 |
Warren Chan |
Stable, water-soluble quantum dot, method of preparation and conjugates thereof
|
|
PT1844337E
(pt)
|
2005-01-24 |
2014-04-03 |
Pepscan Systems Bv |
Compostos ligantes, compostos imunogénicos e peptidomiméticos
|
|
PL1866328T3
(pl)
|
2005-03-22 |
2011-05-31 |
Rohto Pharma |
Peptydy zwiększające wytwarzanie kolagenu lub kwasu hialuronowego
|
|
AU2006287416A1
(en)
|
2005-09-07 |
2007-03-15 |
Medimmune, Llc |
Toxin conjugated Eph receptor antibodies
|
|
WO2007093836A1
(en)
|
2006-02-13 |
2007-08-23 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof
|
|
CA2663454C
(en)
|
2006-09-15 |
2015-04-21 |
Siemens Medical Solutions Usa, Inc. |
Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins
|
|
CN101232326B
(zh)
|
2007-01-22 |
2012-01-11 |
中兴通讯股份有限公司 |
用于无源光网络系统的动态带宽分配装置及其实现方法
|
|
WO2008134761A2
(en)
|
2007-04-30 |
2008-11-06 |
Intezyne Technologies, Inc. |
Modification of biological targeting groups for the treatment of cancer
|
|
KR20100056438A
(ko)
|
2007-06-18 |
2010-05-27 |
메디뮨 엘엘씨 |
ＥｐｈＡ2 및 ＥｒｂＢ2를 발현하는 세포의 상승적 치료 방법
|
|
CN101497878B
(zh)
|
2008-01-30 |
2012-11-07 |
房学迅 |
特异性高效亲和膜ⅰ型基质金属蛋白酶(mt1-mmp)的多肽、蛋白及其应用
|
|
WO2009097397A2
(en)
|
2008-01-30 |
2009-08-06 |
Dyax Corp. |
Metalloproteinase binding proteins
|
|
WO2009098450A2
(en)
|
2008-02-05 |
2009-08-13 |
Medical Research Council |
Methods and compositions
|
|
DK2257309T3
(da)
|
2008-02-27 |
2020-01-20 |
Yeda Res And Development Company Ltd |
Rgd-(bakterie)chlorophyl-konjugater til anvendelse ved diagnose af tumorer, der omfatter nekrotiske domæner
|
|
US8293714B2
(en)
|
2008-05-05 |
2012-10-23 |
Covx Technology Ireland, Ltd. |
Anti-angiogenic compounds
|
|
FR2932189A1
(fr)
|
2008-06-10 |
2009-12-11 |
Commissariat Energie Atomique |
Biopuces pour la detection de l'activite enzymatique d'une enzyme protease
|
|
GB0913775D0
(en)
|
2009-08-06 |
2009-09-16 |
Medical Res Council |
Multispecific peptides
|
|
AU2010249719A1
(en)
|
2009-05-19 |
2012-05-31 |
Aic Blab Company |
Composite current collector and methods therefor
|
|
GB0914110D0
(en)
|
2009-08-12 |
2009-09-16 |
Medical Res Council |
Peptide libraries
|
|
EA021897B1
(ru)
|
2009-11-23 |
2015-09-30 |
Палатин Текнолоджиз, Инк. |
Циклические пептиды, специфичные к рецептору меланокортина-1
|
|
WO2011079015A1
(en)
|
2009-12-21 |
2011-06-30 |
The Regents Of The University Of California |
Rgd-containing cyclic peptides
|
|
EP2343081A1
(en)
|
2009-12-31 |
2011-07-13 |
Rijksuniversiteit Groningen |
Interferon analogs
|
|
WO2012057624A1
(en)
|
2010-10-25 |
2012-05-03 |
Pepscan Systems B.V. |
Novel bicyclic peptide mimetics
|
|
US20130072598A1
(en)
|
2011-03-18 |
2013-03-21 |
Board Of Regents Of The University Of Nebraska |
Thermoplastics from Distillers Dried Grains and Feathers
|
|
RU2745572C2
(ru)
|
2011-10-07 |
2021-03-29 |
БайсиклРД Лимитед |
Модуляция специфичности структурированных белков
|
|
GB201117428D0
(en)
|
2011-10-07 |
2011-11-23 |
Bicycle Therapeutics Ltd |
Structured polypeptides with sarcosine linkers
|
|
BR112015006368B1
(pt)
|
2012-09-24 |
2022-02-08 |
Medimmune Limited |
Processo para produção de linha celular eucariótica estável
|
|
WO2014063012A1
(en)
|
2012-10-19 |
2014-04-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Conjugated knottin mini-proteins containing non-natural amino acids
|
|
US10450354B2
(en)
|
2013-03-12 |
2019-10-22 |
Molecular Templates, Inc. |
CD20-binding immunotoxins for inducing cellular internalization and methods using same
|
|
US20140274759A1
(en)
|
2013-03-15 |
2014-09-18 |
Bicycle Therapeutics Limited |
Modification of polypeptides
|
|
US10233249B2
(en)
|
2013-03-19 |
2019-03-19 |
Beijing Shenogen Pharma Group Ltd. |
Antibodies and methods for treating estrogen receptor-associated diseases
|
|
GB201306623D0
(en)
|
2013-04-11 |
2013-05-29 |
Bicycle Therapeutics Ltd |
Modulation of structured polypeptide specificity
|
|
EP2999483B1
(en)
|
2013-05-23 |
2018-10-31 |
Ohio State Innovation Foundation |
Chemical synthesis and screening of bicyclic peptide libraries
|
|
KR102488220B1
(ko)
|
2013-09-25 |
2023-01-12 |
싸이톰스 테라퓨틱스, 인크. |
매트릭스 메탈로프로테이나제 기질 및 다른 절단성 모이어티 및 이의 사용 방법
|
|
US10294274B2
(en)
|
2013-10-28 |
2019-05-21 |
Bicyclerd Limited |
Polypeptide ligands specific for plasma kallikrein
|
|
EP3527569B1
(en)
|
2014-02-03 |
2021-08-25 |
Vitae Pharmaceuticals, LLC |
Dihydropyrrolopyridine inhibitors of ror-gamma for use in treating drye eye
|
|
CN106415269B
(zh)
|
2014-05-08 |
2020-11-27 |
贵州美鑫达医疗科技有限公司 |
直接免疫组织化学测定
|
|
HUE045872T2
(hu)
|
2014-05-21 |
2020-01-28 |
Entrada Therapeutics Inc |
Sejteket penetráló peptidek és ezek elõállítására és alkalmazására szolgáló eljárások
|
|
GB201416960D0
(en)
|
2014-09-25 |
2014-11-12 |
Antikor Biopharma Ltd |
Biological materials and uses thereof
|
|
CN115093463A
(zh)
|
2014-09-30 |
2022-09-23 |
波利弗尔股份公司 |
β-发夹肽模拟物
|
|
AU2015335725B2
(en)
|
2014-10-24 |
2021-06-03 |
Research Corporation Technologies, Inc. |
Small antibody-like polypeptides that bind to EphA2 receptor
|
|
KR102754019B1
(ko)
|
2014-10-29 |
2025-01-14 |
바이시클러드 리미티드 |
Mt1-mmp에 특이적인 바이사이클릭 펩타이드 리간드
|
|
WO2016070089A2
(en)
|
2014-10-31 |
2016-05-06 |
Abbvie Biotherapeutics Inc. |
Anti-cs1 antibodies and antibody drug conjugates
|
|
US10335495B2
(en)
|
2014-12-04 |
2019-07-02 |
Celgene Corporation |
Biomolecule conjugates
|
|
IL237525A
(en)
|
2015-03-03 |
2017-05-29 |
Shalom Eli |
Method for labeling a prostate-specific membrane antigen with a radioactive isotope
|
|
CN107529836A
(zh)
|
2015-04-22 |
2018-01-02 |
三井化学株式会社 |
具有关节用支撑体部的衣物、及膝用支撑体
|
|
WO2016171242A1
(ja)
|
2015-04-24 |
2016-10-27 |
第一三共株式会社 |
Ｅｐｈａ２の検出
|
|
CN107810190A
(zh)
|
2015-04-28 |
2018-03-16 |
洛桑联邦政府综合工科学校（Epfl) |
酶活化因子XII (FXIIa)的新型抑制剂
|
|
EA201792441A2
(ru)
|
2015-05-06 |
2018-06-29 |
Янссен Байотек, Инк. |
Домены фибронектина типа iii, связывающиеся с простатспецифическим мембранным антигеном
|
|
EP3115066A1
(en)
|
2015-07-07 |
2017-01-11 |
Technische Universität München |
Novel psma-specific binding proteins
|
|
US9963495B2
(en)
|
2015-10-27 |
2018-05-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Polypeptides targeting vascular endothelial growth factor receptor and prostate specific membrane antigen
|
|
EP3181146A1
(en)
|
2015-12-16 |
2017-06-21 |
Ruprecht-Karls-Universität Heidelberg |
Cyclic ntcp-targeting peptides and their uses as entry inhibitors
|
|
GB201600911D0
(en)
*
|
2016-01-18 |
2016-03-02 |
Bicycle Therapeutics Ltd |
Stabilized peptide derivatives
|
|
GB201600903D0
(en)
*
|
2016-01-18 |
2016-03-02 |
Bicycle Therapeutics Ltd |
Peptide derivaties
|
|
WO2017160879A1
(en)
|
2016-03-15 |
2017-09-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Knottin-drug conjugates and methods of using the same
|
|
JP2019512477A
(ja)
|
2016-03-16 |
2019-05-16 |
メリマック ファーマシューティカルズ インコーポレーティッド |
エフリン受容体ａ２（ｅｐｈａ２）のナノリポソーム標的化及び関連する診断
|
|
KR102775461B1
(ko)
|
2016-04-01 |
2025-02-28 |
어비디티 바이오사이언시스 인크. |
핵산-폴리펩타이드 조성물 및 이의 용도
|
|
MX2018012803A
(es)
|
2016-04-20 |
2019-06-24 |
Hangzhou Dac Biotech Co Ltd |
Derivados de las toxinas de amanita y su conjugacion a una molecula de union celular.
|
|
WO2017182672A1
(en)
|
2016-04-22 |
2017-10-26 |
Alligator Bioscience Ab |
Novel bispecific polypeptides against cd137
|
|
GB201607827D0
(en)
|
2016-05-04 |
2016-06-15 |
Bicycle Therapeutics Ltd |
Bicyclic peptide-toxin conjugates specific for MT1-MMP
|
|
KR20190014525A
(ko)
|
2016-05-27 |
2019-02-12 |
애브비 바이오테라퓨틱스 인크. |
면역 조절 단백질과 종양 항원을 결합하는 이중특이적 결합 단백질
|
|
US10441663B2
(en)
|
2016-11-27 |
2019-10-15 |
Bicyclerd Limited |
Methods for treating cancer
|
|
US11730819B2
(en)
|
2016-12-23 |
2023-08-22 |
Bicycletx Limited |
Peptide derivatives having novel linkage structures
|
|
CA3046156A1
(en)
|
2016-12-23 |
2018-06-28 |
Bicycletx Limited |
Peptide ligands for binding to mt1-mmp
|
|
WO2018127699A1
(en)
|
2017-01-06 |
2018-07-12 |
Bicyclerd Limited |
Compounds for treating cancer
|
|
JP7132232B2
(ja)
|
2017-02-24 |
2022-09-06 |
マクロジェニクス，インコーポレーテッド |
Ｃｄ１３７及び腫瘍抗原に結合できる二重特異性結合分子並びにその使用
|
|
GB201706477D0
(en)
|
2017-04-24 |
2017-06-07 |
Bicycle Therapeutics Ltd |
Modification of polypeptides
|
|
US10857196B2
(en)
|
2017-04-27 |
2020-12-08 |
Bicycletx Limited |
Bicyclic peptide ligands and uses thereof
|
|
WO2018222987A1
(en)
|
2017-06-01 |
2018-12-06 |
Tarveda Therapeutics, Inc. |
Targeted constructs
|
|
CN111032678A
(zh)
|
2017-06-26 |
2020-04-17 |
拜西克尔德有限公司 |
具有可检测部分的双环肽配体和其用途
|
|
ES2926195T3
(es)
|
2017-08-04 |
2022-10-24 |
Bicycletx Ltd |
Ligandos peptídicos bicíclicos específicos de CD137
|
|
WO2019034866A1
(en)
|
2017-08-14 |
2019-02-21 |
Bicyclerd Limited |
BICYCLIC PEPTIDE LIGANDS CONJUGATES AND USES THEREOF
|
|
EP3668550A1
(en)
|
2017-08-14 |
2020-06-24 |
Bicyclerd Limited |
Bicyclic peptide ligand prr-a conjugates and uses thereof
|
|
WO2019084060A1
(en)
|
2017-10-24 |
2019-05-02 |
Silverback Therapeutics, Inc. |
CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS
|
|
IL313068A
(en)
|
2017-11-07 |
2024-07-01 |
Regeneron Pharma |
Hydrophilic linkers for antibody drug conjugates
|
|
TWI825046B
(zh)
|
2017-12-19 |
2023-12-11 |
英商拜西可泰克斯有限公司 |
Epha2特用之雙環胜肽配位基
|
|
GB201721265D0
(en)
|
2017-12-19 |
2018-01-31 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for EphA2
|
|
WO2019136442A1
(en)
|
2018-01-08 |
2019-07-11 |
Kleo Pharmaceuticals, Inc. |
Cd16a binding agents and uses thereof
|
|
AU2019224659A1
(en)
|
2018-02-23 |
2020-10-15 |
Bicycletx Limited |
Multimeric bicyclic peptide ligands
|
|
WO2019193328A1
(en)
|
2018-04-04 |
2019-10-10 |
Bicycletx Limited |
Heterotandem bicyclic peptide complexes
|
|
WO2019226617A1
(en)
|
2018-05-21 |
2019-11-28 |
Compass Therapeutics Llc |
Compositions and methods for enhancing the killing of target cells by nk cells
|
|
GB201810329D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to integrin avB3
|
|
GB201810320D0
(en)
*
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to CD38
|
|
GB201810316D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicyclerd Ltd |
Peptide ligands for binding to EphA2
|
|
GB201810327D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to IL-17
|
|
GB201810325D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to PSMA
|
|
US11180531B2
(en)
|
2018-06-22 |
2021-11-23 |
Bicycletx Limited |
Bicyclic peptide ligands specific for Nectin-4
|
|
US10919937B2
(en)
|
2018-10-23 |
2021-02-16 |
Bicycletx Limited |
Bicyclic peptide ligands and uses thereof
|
|
SG11202104356VA
(en)
|
2018-10-30 |
2021-05-28 |
Bicyclerd Ltd |
Bt1718 for use in treating cancer
|
|
GB201820325D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for psma
|
|
GB201820295D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for MT1-MMP
|
|
GB201820288D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicycle Tx Ltd |
Bicycle peptide ligaands specific for MT1-MMP
|
|
SG11202106081YA
(en)
|
2018-12-13 |
2021-07-29 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for mt1-mmp
|
|
EP3897851A2
(en)
|
2018-12-17 |
2021-10-27 |
Revitope Limited |
Twin immune cell engager
|
|
US12551567B2
(en)
|
2018-12-21 |
2026-02-17 |
Bicyclerd Limited |
Bicyclic peptide ligands specific for PD-L1
|
|
CN113474045A
(zh)
|
2018-12-21 |
2021-10-01 |
拜斯科技术开发有限公司 |
Pd-l1特异性的双环肽配体
|
|
US10882987B2
(en)
|
2019-01-09 |
2021-01-05 |
Nova Chemicals (International) S.A. |
Ethylene interpolymer products having intermediate branching
|
|
GB201900530D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for CD38
|
|
GB201900529D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for CD38
|
|
GB201900526D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for caix
|
|
GB201900525D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for caix
|
|
GB201900527D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for integrin avb3
|
|
GB201900528D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for integrin AVB3
|
|
WO2020165600A1
(en)
|
2019-02-14 |
2020-08-20 |
Bicycletx Limited |
Bicyclic peptide ligand sting conjugates and uses thereof
|
|
WO2020178574A1
(en)
|
2019-03-04 |
2020-09-10 |
Bicyclerd Limited |
Synthesis of bicycle toxin conjugates, and intermediates thereof
|
|
JP2022528887A
(ja)
|
2019-04-02 |
2022-06-16 |
バイスクルテクス・リミテッド |
バイシクルトキシンコンジュゲートおよびその使用
|
|
AU2020269506A1
(en)
|
2019-05-09 |
2022-01-06 |
Bicycletx Limited |
Bicyclic peptide ligands specific for OX40
|
|
TWI869398B
(zh)
|
2019-05-10 |
2025-01-11 |
英商拜西克爾德有限公司 |
治療癌症之方法
|
|
TWI860386B
(zh)
|
2019-07-30 |
2024-11-01 |
英商拜西可泰克斯有限公司 |
異質雙環肽複合物
|
|
EP4013501A1
(en)
|
2019-08-13 |
2022-06-22 |
BicycleTX Limited |
Modified multimeric bicyclic peptide ligands
|
|
GB201912320D0
(en)
|
2019-08-28 |
2019-10-09 |
Bicycletx Ltd |
PBP Binding Bicyclic Peptide Ligands
|
|
CN119192401A
(zh)
|
2019-10-03 |
2024-12-27 |
拜斯科技术开发有限公司 |
异串联双环肽复合物
|
|
GB201914872D0
(en)
|
2019-10-15 |
2019-11-27 |
Bicycletx Ltd |
Bicyclic peptide ligand drug conjugates
|
|
WO2021074647A1
(en)
|
2019-10-16 |
2021-04-22 |
Bicyclerd Limited |
Methods for treating cancer
|
|
US20230025916A1
(en)
|
2019-11-27 |
2023-01-26 |
Bicycle TX Limited |
BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2 AND USES THEREOF
|
|
IT202000001231A1
(it)
|
2020-01-22 |
2021-07-22 |
Celery S R L |
Nuovi ceppi di batteri lattici, composizione alimentare che li comprende, preparazione di tale composizione
|
|
GB202002706D0
(en)
|
2020-02-26 |
2020-04-08 |
Bicycletx Ltd |
Pbp3 binding bicyclic peptide ligands
|
|
GB202002705D0
(en)
|
2020-02-26 |
2020-04-08 |
Bicycletx Ltd |
Anti-infective bicyclic peptide conjugates
|
|
CN115697417A
(zh)
|
2020-05-20 |
2023-02-03 |
拜斯科技术开发有限公司 |
Nectin-4特异性的双环肽配体及其用途
|
|
US20230233698A1
(en)
|
2020-06-12 |
2023-07-27 |
Bicycletx Limited |
Treatment of diseases characterized by overexpression of erythropoietin-producing hepatocellular receptor a2 (epha2)
|
|
CA3189761A1
(en)
|
2020-08-03 |
2022-02-10 |
Gemma Mudd |
Peptide-based linkers
|
|
KR20230074721A
(ko)
|
2020-08-17 |
2023-05-31 |
바이사이클티엑스 리미티드 |
Nectin-4에 특이적인 이환 콘쥬게이트 및 이의 용도
|
|
WO2022148974A2
(en)
|
2021-01-08 |
2022-07-14 |
Bicycletx Limited |
Bicyclic peptide ligands specific for nk cells
|
|
WO2022148969A1
(en)
|
2021-01-08 |
2022-07-14 |
Bicycletx Limited |
Anti-infective bicyclic peptide ligands
|
|
US20240197897A1
(en)
|
2021-01-08 |
2024-06-20 |
Bicycle TX Limited |
Heterotandem bicyclic peptide complexes
|
|
US20250186539A2
(en)
|
2021-01-11 |
2025-06-12 |
Bicycletx Limited |
Methods for treating cancer
|
|
CA3229976A1
(en)
|
2021-09-03 |
2023-03-09 |
Bicycletx Limited |
Synthesis of bicycle toxin conjugates, and intermediates thereof
|
|
WO2023089308A1
(en)
|
2021-11-16 |
2023-05-25 |
Bicycletx Limited |
Methods for treating cancer
|